In this insightful webinar we explore how Cresset leverages AI to transform the drug discovery process. Our Vice President of AI, Dr. Mutlu Dogruel, discusses the integration of AI technologies to optimize workflows, enhance productivity, and empower decision-making. We also showcase how our recent acquisition of Molab.ai enhances our capabilities with ADMET property prediction, providing a complementary solution to empower end-users.
Key topics include:
- AI Empowerment: Learn how AI bots, coding assistants, and autonomous agents are revolutionizing software engineering and application orchestration at Cresset.
- Strategic AI Pillars: Explore our commitment to responsible AI, emphasizing transparency, fairness, and ethical use, alongside our systematic approach to developing scalable AI solutions.
- Productivity Tools: Discover how AI-generated reports and Flare enhance user experience and streamline operations, providing actionable insights in drug discovery.
- Active Learning in Drug Discovery: Understand the role of AI in accelerating clinical candidate identification, integrating Free Energy Perturbation (FEP) with AI for optimized lead generation.
